Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Neurosciences
This study is designed to validate intracranial pressure measurements obtained with a novel, self-calibrating, non-invasive, intracranial pressure measuring (ICP) device based on trans-cranial Doppler technology. The ophthalmic artery is utilized as a natural ICP sensor. Up to 80 subjects will be recruited in 4 centers to achieve a power of 90% and a p\<0.05 compared to the values obtained from (a) patients in an ICU whose meet standard clinical indications for ICP measurement and whose ICP is measured using gold-standard implanted intracranial instrumentation and in (b) ambulatory subjects who meet clinical indications for lumbar puncture. At least two comparative readings, separated by an hour or more, will be obtained from each subject.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
ICU patients suspected of having an abnormality of ICP undergoing monitoring with commercially-available, FDA-approved instrumentation.
You may not be if
History of:
Glaucoma or optic hypertension
Severe orbital or ophthalmic injury
Orbital or intraocular surgery that might interfere with orbital compliance
Congenital malformations of the eye and/or orbit that might interfere with orbital compliance or orbital vascular anatomy